Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PAF ANTAGONIST' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 153 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Qian, CG; Hwang, SB; Libertine-Garahan, L; Eckman, JB; Cai, X; Scannell, RT; Yeh, CG
      Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor

      PHARMACOLOGICAL RESEARCH
    2. Lloberas, N; Cruzado, JM; Torras, J; Herrero-Fresneda, I; Riera, M; Merlos, M; Grinyo, JM
      Protective effect of UR-12670 on chronic nephropathy induced by warm ischaemia in ageing uninephrectomized rats

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    3. Iwazaki, S; Takeyoshi, I; Ohwada, S; Sunose, Y; Tsutsumi, H; Kawashima, Y; Matsumoto, K; Morishita, Y
      FR128998 ameliorates liver injury in extended liver resection with ischemia in dogs

      HEPATO-GASTROENTEROLOGY
    4. Hayashi, J; Hiromura, K; Koizumi, R; Shimizu, Y; Maezawa, A; Nojima, V; Naruse, T
      Platelet-activating factor antagonist, SM-12502, attenuates experimental glomerular thrombosis in rats

      NEPHRON
    5. Araujo, CV; Barbosa, JM; Cordeiro, RSB; Tibirica, E
      Protective effects of yangambin on cardiovascular hyporeactivity to catecholamines in rats with endotoxin-induced shock

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    6. Kawaguchi, A; Sugimoto, K; Fujimura, A
      Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity

      LIFE SCIENCES
    7. Gomez, FP; Rodriguez-Roisin, R
      Platelet-activating factor antagonists - Current status in asthma

      BIODRUGS
    8. Henig, NR; Aitken, ML; Liu, MC; Yu, AS; Henderson, WR
      Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    9. Wereszczynska-Siemiatkowska, U; Dlugosz, JW; Siemiatkowski, A; Chyczewski, L; Gabryelewicz, A
      Lysosomal activity of pulmonary alveolar macrophages in acute experimentalpancreatitis in rats with reference to positive PAF-antagonist (BN 52021) effect

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    10. Asai, Y; Murahashi, N; Iwamoto, K
      Optimization of the formulation and characterization of the physicochemical properties of the novel platelet-activating factor receptor antagonist E5880

      DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    11. Asai, Y; Nomura, T; Murahashi, N; Iwamoto, K
      Characterization of the physicochemical properties of the micelles of platelet-activating factor (C-18 : 0)

      DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    12. Asai, Y; Nomura, T; Murahashi, N; Iwamoto, T
      A temperature study on critical micellization concentration of the novel platelet-activating factor receptor antagonist E5880 in water by electric conductivity measurements

      DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    13. Rabinovici, R; Spirig, A; Abdullah, F; Phillip, DR; Ovadia, P; Rudolph, A
      Liposome-encapsulated hemoglobin does not exacerbate endotoxin-induced lung injury

      CRITICAL CARE MEDICINE
    14. Pei, WW; Pei, J; Li, SH; Ye, XL
      Stereoselective synthesis of 2-aryltetrahydrofuran-3,4-dicarboxylate derivatives: Efficient approach to tetrahydrofuran lignans

      SYNTHESIS-STUTTGART
    15. Mahmoud, F; Abul, H; Onadeko, B; Khadadah, M; Haines, D; Morgan, G
      In vitro effects of Ginkgolide B on lymphocyte activation in atopic asthma: Comparison with cyclosporin A

      JAPANESE JOURNAL OF PHARMACOLOGY
    16. Nomura, T; Asai, Y; Murahashi, N; Iwamoto, K
      Formation of spherical micelles by the novel platelet activating factor receptor antagonist, E5880

      CHEMICAL & PHARMACEUTICAL BULLETIN
    17. Souza, DG; Cara, DC; Cassali, GD; Coutinho, SF; Silveira, MR; Andrade, SP; Poole, SP; Teixeira, MM
      Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat

      BRITISH JOURNAL OF PHARMACOLOGY
    18. Galvez, J; Garrido, M; Merlos, M; Torres, MI; Zarzuelo, A
      Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat

      BRITISH JOURNAL OF PHARMACOLOGY
    19. Kim, JD; Baker, CJ; Roberts, RF; Darbinian, SH; Marcus, KA; Quardt, SM; Starnes, VA; Barr, ML
      Platelet activating factor acetylhydrolase decreases lung reperfusion injury

      ANNALS OF THORACIC SURGERY
    20. Imrie, CW; McKay, CJ
      The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    21. Johnson, A; Broadley, KJ
      Airway hyperresponsiveness in anaesthetised guinea-pigs 18-24 hours after antigen inhalation does not occur with all intravenously administered spasmogens

      PHARMACOLOGY & TOXICOLOGY
    22. Yamaguchi, Y; Matsumura, F; Liang, J; Okabe, K; Matsuda, T; Ohshiro, H; Ishihara, K; Akizuki, E; Yamada, S; Ogawa, M
      Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats

      PANCREAS
    23. Bielory, L; Lupoli, K
      Herbal interventions in asthma and allergy

      JOURNAL OF ASTHMA
    24. Lopez-Novoa, JM
      Potential role of platelet activating factor in acute renal failure

      KIDNEY INTERNATIONAL
    25. Kim, KA; Moon, TC; Lee, SW; Chung, KC; Han, BH; Chang, HW
      Pinusolide from the leaves of Biota orientalis as potent platelet activating factor antagonist

      PLANTA MEDICA
    26. Uluoglu, C; Timlioglu, O
      Endothelium-dependent vasodilation in the isolated rabbit kidney followingin vivo and in vitro ischaemia and reperfusion: effects of antagonizing platelet activating factor (PAF)

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    27. Komatsu, H; Amano, M; Yamaguchi, S; Sugahara, K
      Inhibition of activation of human peripheral blood eosinophils by Y-24180,an antagonist to platelet-activating factor receptor

      LIFE SCIENCES
    28. Shan, L; Nishimura, Y; Kotani, Y; Yokoyama, M
      Platelet-activating factor increases the expression of metalloproteinase-9in human bronchial epithelial cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    29. Suzuki, T; Nagaoka, H; Hara, H; Takeuchi, M; Saito, M; Yamada, T; Tomioka, K; Matsumoto, H; Takanuki, K; Mase, T
      2-(3-pyridyl)thiazolidine-4-carboxamide derivatives. III. Synthesis of metabolites and metabolism of 2-(3-pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as platelet-activating factor (PAF) receptor antagonists

      CHEMICAL & PHARMACEUTICAL BULLETIN
    30. Caballero, R; Valenzuela, C; Longobardo, M; Tamargo, J; Delpon, E
      Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac Kv1.5 channels

      BRITISH JOURNAL OF PHARMACOLOGY
    31. Wang, X; Bae, JH; Kim, SU; McLarnon, JG
      Platelet-activating factor induced Ca2+ signaling in human microglia

      BRAIN RESEARCH
    32. GOMEZ FP; ROCA J; BARBERA JA; CHUNG KF; PEINADO VI; RODRIGUEZROISIN R
      EFFECT OF A PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONIST, SR-27417A, ON PAF-INDUCED GAS-EXCHANGE ABNORMALITIES IN MILD ASTHMA

      The European respiratory journal
    33. TIBBALLS J
      THE CARDIOVASCULAR, COAGULATION AND HEMATOLOGICAL EFFECTS OF TIGER SNAKE (NOTECHIS SCUTATUS) PROTHROMBIN ACTIVATOR AND INVESTIGATION OF RELEASE OF VASOACTIVE SUBSTANCES

      Anaesthesia and intensive care
    34. SHI HX; LIN H; BLOCH R; MANDVILL G
      A NOVEL-APPROACH TO SYNTHESIZE TRANS-2,5- DIARYLTETRAHYDROFURAN

      Gaodeng xuexiao huaxue xuebao
    35. MASUYAMA K; TORIYA T; MINODA R; EURA M; SAMEJIMA Y; ISHIKAWA T
      PAF-RECEPTOR AND HISTAMINE-RECEPTOR ANTAGONISTS LESSEN ALLERGEN-INDUCED HEARING IMPAIRMENT IN GUINEA-PIGS

      Prostaglandins
    36. Dhainaut, JFA; Tenaillon, A; Hemmer, M; Damas, P; Le Tulzo, Y; Radermacher, P; Schaller, MD; Sollet, JP; Wolff, M; Holzapfel, L; Zeni, F; Vedrinne, JM; de Vathaire, F; Gourlay, ML; Guinot, P; Mira, JP; Holzapfel, L; Demingeon, G; Piralla, B; Zeni, F; Bertrand, JC; Motin, J; Vedrinne, JM; Dreyfuss, D; Coste, F; Mier, L; Faller, JP; Ruyer, O; Feissel, M; Engquist, A; Strom, J; Bonde, J; Desmonts, JM; Montravers, P; Lagoueyte, JF; Tenaillon, A; Lawkoune, JM; Boiteau, R; Cardinaud, JP; Benissan, G; Chastre, J; Gibert, C; Daoudal, P; Delacourt, M; Fouet, P; Hilpert, F; Smithies, M; Bihari, D; Perrotin, D; Dequin, PF; Tempelhof, G; Carton, MJ; Payen, D; Mateo, J; Carlet, J; Lescale, O; Bleichner, G; Sollet, JP; Fagon, JY; Novara, A; Dhainaut, JF; Marin, N; Galiacy, JL; Morteau, B; Wolff, M; Vachon, F; Durocher, A; Saulnier, F; Herman, B; Wysocki, M; Duswald, M; Radermacher, P; Georgieff, M; Colardyn, F; Robert, D; Park, G; Mattei, M; Charbonneau, P; Chopin, C; Breulmann, M; Holzheimer, M; Damas, F; Ozier, Y; Fraisse, F; Gastrinne, H; Blanc, PL; Domart, Y; Aube, H; Descamps, JM; Nitenberg, G; Tempe, JD; Bonnet, F; Jaeger, A; Villers, D; Barale, F; Falke, K; Ulbricht, M; Samii, K; Pepperman, M; Tonnesen, E; Gattinoni, L; Braschi, A; Arich, C; Lienhart, A; Offenstadt, G; Eurin, B; Schlemmer, B; Goenen, M; Bahr, R; Brienza, A; Antonelli, M; Damas, P; Edwards, D
      Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial

      CRITICAL CARE MEDICINE
    37. SINGH N; SHARMA A; SINGH M
      POSSIBLE MECHANISM OF ALPRAZOLAM-INDUCED AMNESIA IN MICE

      Pharmacology
    38. HAN L; YANG H; SHIMADA T; HIROSE T; KOYANAGI M; MATSUMOTO I; IWASAKI K; AIKAWA T
      EFFECT OF PAF RECEPTOR ANTAGONISTS ON ADRENOCORTICAL SECRETION INDUCED BY ACTH IN NORMAL AND ATHYMIC NUDE-MICE

      Life sciences
    39. EVANS DJ; BARNES PJ; CLUZEL M; OCONNOR BJ
      EFFECTS OF A POTENT PLATELET-ACTIVATING-FACTOR ANTAGONIST, SR27417A, ON ALLERGEN-INDUCED ASTHMATIC RESPONSES

      American journal of respiratory and critical care medicine
    40. SPAPEN H; ZHANG HB; VERHAEGHE V; ROGIERS P; CABRAL A; VINCENT JL
      TREATMENT WITH A PLATELET-ACTIVATING-FACTOR ANTAGONIST HAS LITTLE PROTECTIVE EFFECTS DURING ENDOTOXIC-SHOCK IN THE DOG

      Shock
    41. QAYUMI AK; ENGLISH JE; DUNCAN S; ANSLEY DM; PEARSON B; NIKBAKHTSANGARI M; SAMMARTINO C; FRADET G
      EXTENDED LUNG PRESERVATION WITH PLATELET-ACTIVATING FACTOR-ANTAGONISTTCV-309 IN COMBINATION WITH PROSTAGLANDIN E-1

      The Journal of heart and lung transplantation
    42. JUNG KY; LEE IS; OH SR; KIM DS; LEE HK
      LIGNANS WITH PLATELET-ACTIVATING-FACTOR ANTAGONIST ACTIVITY FROM SCHISANDRA-CHINENSIS (TURCZ.) BAILL

      Phytomedicine
    43. BALSA D; MERLOS M; GIRAL M; FERRANDO R; GARCIARAFANELL J; FORN J
      EFFECT OF ENDOTOXIN AND PLATELET-ACTIVATING-FACTOR ON RAT VASCULAR-PERMEABILITY - ROLE OF VASOACTIVE MEDIATORS

      Journal of lipid mediators and cell signalling
    44. MASSICOT F; LAMOURI A; MARTIN C; PHAMHUY C; HEYMANS F; WARNET JM; GODFROID JJ; CLAUDE JR
      PREVENTIVE EFFECTS OF 2 PAF-ANTAGONISTS, PMS 536 AND PMS 549, ON CYCLOSPORINE-INDUCED LLC-PK1 OXIDATIVE INJURY

      Journal of lipid mediators and cell signalling
    45. LOUCKS EB; SYMERSKY P; QAYUMI AK
      PLATELET-ACTIVATING-FACTOR ANTAGONISM - A NEW CONCEPT IN THE MANAGEMENT OF REGIONAL MYOCARDIAL ISCHEMIA-REPERFUSION INJURY

      Journal of investigative surgery
    46. SINGH N; SHARMA A; SINGH M
      EFFECTS OF BN-50730 (PAF RECEPTOR ANTAGONIST) AND PHYSOSTIGMINE (ACHEINHIBITOR) ON LEARNING AND MEMORY IN MICE

      Methods and findings in experimental and clinical pharmacology
    47. LEE IS; JUNG KY; OH SR; KIM DS; KIM JH; LEE JJ; LEE HK; LEE SH; KIM EH; CHEONG C
      PLATELET-ACTIVATING-FACTOR ANTAGONISTIC ACTIVITY AND C-13 NMR ASSIGNMENT OF PREGOMISIN AND CHAMIGRENAL FROM SCHISANDRA-CHINENSIS

      Archives of pharmacal research
    48. BIX GJ; CLARK GD
      ELVAX AS A SLOW-RELEASE DELIVERY AGENT FOR A PLATELET-ACTIVATING-FACTOR RECEPTOR AGONIST AND ANTAGONIST

      Journal of neuroscience methods
    49. HERBERTSON MJ; WEMER HA; WALLEY KR
      PLATELET-ACTIVATING-FACTOR ANTAGONISM IMPROVES VENTRICULAR CONTRACTILITY IN ENDOTOXEMIA

      Critical care medicine
    50. ZENG HW; JIANG YY; CAI DG; BIAN J; LONG K; CHEN ZL
      PIPERBETOL, METHYLPIPERBETOL, PIPEROL-A AND PIPEROL-B - A NEW SERIES OF HIGHLY SPECIFIC PAF RECEPTOR ANTAGONISTS FROM PIPER BETLE

      Planta medica
    51. KAGOSHIMA M; TOMOMATSU N; IWAHISA Y; YAMAGUCHI S; KAWAKAMI Y; TERASAWA M
      EFFECTS OF Y-24180, A LONG-ACTING AND POTENT ANTAGONIST TO PLATELET-ACTIVATING-FACTOR, ON IMMEDIATE ASTHMATIC RESPONSE IN GUINEA-PIGS

      Pharmacology
    52. LIN CH; KO FN; ISHII H; ISHIKAWA T; CHEN KS; TENG CM; KUO HP
      THE EFFECT OF THE SELECTIVE PAF ANTAGONIST CIS-19 ON PAF-INDUCED AND ANTIGEN-INDUCED BRONCHOCONSTRICTION, MICROVASCULAR LEAKAGE AND BRONCHIAL HYPERREACTIVITY IN GUINEA-PIGS

      Naunyn-Schmiedeberg's archives of pharmacology
    53. PALMER JS; CROMIE WJ; PLZAK LF; LEFF AR
      A PLATELET-ACTIVATING FACTORS ANTAGONIST ATTENUATES THE EFFECTS OF TESTICULAR ISCHEMIA

      The Journal of urology
    54. YAMAGUCHI S; KAGOSHIMA M; KOHGE S; TERASAWA M
      SUPPRESSIVE EFFECTS OF Y-24180, A LONG-ACTING ANTAGONIST FOR PLATELET-ACTIVATING-FACTOR, ON ALLERGIC PULMONARY EOSINOPHILIA IN MICE

      Japanese Journal of Pharmacology
    55. ALBERT DH; MAGOC TJ; TAPANG P; LUO GJ; MORGAN DW; CURTIN M; SHEPPARD GS; XU LH; HEYMAN HR; DAVIDSEN SK; SUMMERS JB; CARTER GW
      PHARMACOLOGY OF ABT-491, A HIGHLY POTENT PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST

      European journal of pharmacology
    56. NAGAOKA H; HARA H; SUZUKI T; TAKAHASHI T; TAKEUCHI M; MATSUHISA A; SAITO M; YAMADA T; TOMIOKA K; MASE T
      2-(3-PYRIDYL)THIAZOLIDINE-4-CARBOXAMIDES .1. NOVEL ORALLY-ACTIVE ANTAGONISTS OF PLATELET-ACTIVATING-FACTOR (PAF)

      Chemical and Pharmaceutical Bulletin
    57. AKAGI M; NISHIOKA E; KANOH R; TACHIBANA M; FUKUISHI N
      INHIBITOR EFFECT OF APAFANT ON BRONCHOPULMONARY RESPONSES TO PLATELET-ACTIVATING-FACTOR AND TO ANTIGEN IN RATS

      Arzneimittel-Forschung
    58. FROON AMF; GREVE JWM; BUURMAN WA; VANDERLINDEN CJ; LANGEMEIJER HJM; ULRICH C; BOURGEOIS M
      TREATMENT WITH THE PLATELET-ACTIVATING-FACTOR ANTAGONIST TCV-309 IN PATIENTS WITH SEVERE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME - A PROSPECTIVE, MULTICENTER, DOUBLE-BLIND, RANDOMIZED PHASE-II TRIAL

      Shock
    59. KAHBAK L; ROCHE A; DUBRAY C; ARNOUX C; BENVENISTE J
      DECREASE OF CILIARY BEAT FREQUENCY BY PLATELET-ACTIVATING-FACTOR - PROTECTIVE EFFECT OF KETOTIFEN

      Inflammation research
    60. MEENAN J; GROOL TA; HOMMES DW; DIJKHUIZEN S; TENKATE FJ; WOOD M; WHITTAKER M; TYTGAT GN; VANDEVENTER SJ
      LEXIPAFANT (BB-882), A PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST, AMELIORATES MUCOSAL INFLAMMATION IN AN ANIMAL-MODEL OF COLITIS

      European journal of gastroenterology & hepatology
    61. RIBEIRO R; CARVALHO FAS; BARBOSA JM; CORDEIRO RSB; TIBIRICA EV
      PROTECTIVE EFFECTS OF YANGAMBIN - A NATURALLY-OCCURRING PLATELET-ACTIVATING-FACTOR (PAF) RECEPTOR ANTAGONIST ON ANAPHYLACTIC SHOCK IN RATS

      Phytomedicine
    62. TIBIRICA EV; MOSQUERA K; ABREU M; RIBEIRO R; CARVALHO FAS; BARBOSA JM; CORDEIRO RSB
      ANTAGONISTIC EFFECT OF YANGAMBIN ON PLATELET-ACTIVATING-FACTOR (PAF)-INDUCED CARDIOVASCULAR COLLAPSE

      Phytomedicine
    63. OGURA M; KUBOTA Y; INOUE K
      ROLE OF ENDOGENOUS PLATELET-ACTIVATING-FACTOR IN THE REGULATION OF PANCREATIC BLOOD-FLOW DURING CERULEIN STIMULATION

      Journal of gastroenterology
    64. HEUER HO; WENZ B; JENNEWEIN HM; URICH K
      PHARMACOLOGICAL CHARACTERIZATION OF A NEW MODEL OF ANTIGEN-INDUCED PULMONARY LATE-PHASE REACTION IN THE CONSCIOUS GUINEA-PIG WHICH USES ADDITIONAL POLYMYXIN-B INHALATION

      Journal of lipid mediators and cell signalling
    65. KATO K; ZORUMSKI CF
      PLATELET-ACTIVATING-FACTOR AS A POTENTIAL RETROGRADE MESSENGER

      Journal of lipid mediators and cell signalling
    66. LETEXIER L; FAVRE E; REDEUILH C; BLAVET N; BELLAHSENE T; DIVE G; PIROTZKY E; GODFROID JJ
      STRUCTURE-ACTIVITY-RELATIONSHIPS IN PLATELET-ACTIVATING-FACTOR (PAF) .7. TETRAHYDROFURAN DERIVATIVES AS DUAL PAF ANTAGONISTS AND ACETYLCHOLINESTERASE INHIBITORS - SYNTHESIS AND PAF-ANTAGONISTIC ACTIVITY

      Journal of lipid mediators and cell signalling
    67. LETEXIER L; FAVRE E; RONZANI N; MASSICOT F; BLAVET N; PIROTZKY E; GODFROID JJ
      STRUCTURE-ACTIVITY-RELATIONSHIPS IN PLATELET-ACTIVATING-FACTOR (PAF) .8. TETRAHYDROFURAN DERIVATIVES AS DUAL PAF ANTAGONISTS AND ACETYLCHOLINESTERASE INHIBITORS - ANTIACETYLCHOLINESTERASE ACTIVITY AND COMPARATIVE SAR

      Journal of lipid mediators and cell signalling
    68. GRINYO JM; TORRAS J; VALLES J
      THE ROLE OF PLATELET-ACTIVATING-FACTOR ANTAGONISTS IN THE PROPHYLAXISOF POSTTRANSPLANT ACUTE TUBULAR-NECROSIS

      Renal failure
    69. KIMURA S; WATANABE A; NAGATA M; NIINOMI Y; HARADA M
      HETEROGENEITY OF DRUG SUSCEPTIBILITY OF MOUSE ACTIVE ANAPHYLACTIC SHOCK

      Immunological investigations
    70. KEMENY L; TRACH V; DOBOZY A
      EFFECT OF LOCALLY APPLIED WEB-2086, A PLATELET-ACTIVATING-FACTOR ANTAGONIST, ON INFLAMMATORY SKIN CONDITIONS IN MICE

      Archives of dermatological research
    71. SERIZAWA A; NAKAMURA S; SUZUKI S; BABA S; NAKANO M
      INVOLVEMENT OF PLATELET-ACTIVATING-FACTOR IN CYTOKINE PRODUCTION AND NEUTROPHIL ACTIVATION AFTER HEPATIC ISCHEMIA-REPERFUSION

      Hepatology
    72. KAWAKAMI Y; KITANI H; YUASA S; ABE M; MORIWAKI M; KAGOSHIMA M; TERASAWA M; TAHARA T
      STRUCTURAL OPTIMIZATION OF HIENO[3,2-F]-[1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINES AS ANTAGONISTS FOR PLATELET-ACTIVATING-FACTOR - PHARMACOLOGICAL CONTRIBUTION OF SUBSTITUENTS AT THE 2-POSITION AND 6-POSITION OF A CONDENSED RING-SYSTEM

      European journal of medicinal chemistry
    73. SMITH S; BLACKWELL GJ; DEMAINE DA; GARLAND LG; HODSON HF; HYDE RM; PARKE AJ; ROSE VS; SAWYER DA; TILLING L
      SYNTHESIS AND PAF ANTAGONIST ACTIVITY OF SOME 2,5-DIARYLTETRAHYDROFURANS INCORPORATING PAF-LIKE FUNCTIONAL-GROUPS

      European journal of medicinal chemistry
    74. KOMATSU Y; SHIRATORI Y; HIKIBA Y; HASHIMOTO N; HAN K; KAWASE T; YOSHIDA H; OKANO K; OMATA M
      ROLE OF PLATELET-ACTIVATING-FACTOR IN PATHOGENESIS OF GALACTOSAMINE-LIPOPOLYSACCHARIDE-INDUCED LIVER-INJURY

      Digestive diseases and sciences
    75. GREENBERG SS; XIE JM; POWERS DR; GILES TD
      ETHANOL SUPPRESSES ENDOTOXIN BUT NOT PLATELET-ACTIVATING FACTOR-INDUCED HYPOTENSION AND NITRIC-OXIDE

      Alcoholism, clinical and experimental research
    76. RIGBI M; OREVI M; ELDOR A
      PLATELET-AGGREGATION AND COAGULATION INHIBITORS IN LEECH SALIVA AND THEIR ROLES IN LEECH THERAPY

      Seminars in thrombosis and hemostasis
    77. MIYAOKA H; SAKA Y; MIURA S; YAMADA Y
      TOTAL SYNTHESIS OF PHOMACTIN-D

      Tetrahedron letters
    78. IWAHISA Y; YAMAGUCHI S; KAGOSHIMA M; TERASAWA M
      EFFECT OF Y-24180, A PLATELET-ACTIVATING FACTOR-RECEPTOR ANTAGONIST, ON THE ANTIGEN-INDUCED AIRWAY MICROVASCULAR LEAKAGE IN GUINEA-PIGS

      Japanese Journal of Pharmacology
    79. EBARA T; MIURA K; MATSUURA T; IMANISHI M; YAMANO Y; KIM S; IWAO H
      ROLE OF PLATELET-ACTIVATING-FACTOR AND PROSTANOIDS IN HEMODYNAMIC-CHANGES IN RAT EXPERIMENTAL ENDOTOXIC-SHOCK

      Japanese Journal of Pharmacology
    80. KLOSTERHALFEN B; TONS C; HAUPTMANN S; TIETZE L; OFFNER FA; KUPPER W; KIRKPATRICK CJ
      INFLUENCE OF HEAT-SHOCK PROTEIN-70 AND METALLOTHIONEIN INDUCTION BY ZINC-BIS-(DL-HYDROGENASPARTATE) ON THE RELEASE OF INFLAMMATORY MEDIATORS IN A PORCINE MODEL OF RECURRENT ENDOTOXEMIA

      Biochemical pharmacology
    81. GIUDICE A; HERBERT JM; MAFFRAND JP; MANARA L; MANZONI L; LEFUR G
      PREVENTION OF PLATELET-ACTIVATING FACTOR-INDUCED GASTROINTESTINAL LESIONS IN RATS BY THE NEW SPECIFIC ANTAGONIST HYL)[4-(2,4,6-TRIISOPROPYLPHENYL)THIAZOL-2YL]AMINE

      Arzneimittel-Forschung
    82. LIN JZ; KIM YG; LEES C; JUHN SK
      EFFECTS OF PLATELET-ACTIVATING-FACTOR (PAF) RECEPTOR BLOCKAGE ON MUCOUS GLYCOPROTEIN-SECRETION IN CULTURED CHINCHILLA MIDDLE-EAR EPITHELIUM

      Acta oto-laryngologica
    83. WOOLLEY DS; PUGLISI RN; QUINN JV; SLOTMAN GJ
      PLATELET-ACTIVATING-FACTOR MEDIATES CARDIOPULMONARY DYSFUNCTION DURING GRADED BACTEREMIC SHOCK

      The journal of trauma, injury, infection, and critical care
    84. DOLY M; CLUZEL J; BONHOMME B; MILLERIN M; BRAQUET P
      PROTECTIVE EFFECT OF A SPECIFIC PAF ANTAGONIST ON VINCRISTINE-INDUCEDEXPERIMENTAL RETINOPATHY

      Acta ophthalmologica Scandinavica
    85. BROWN AFT
      ANAPHYLACTIC SHOCK - MECHANISMS AND TREATMENT

      Journal of accident & emergency medicine
    86. KUITERT LM; ANGUS RM; BARNES NC; BARNES PJ; BONE MF; CHUNG KF; FAIRFAX AJ; HIGENBOTHAM TW; OCONNOR BJ; PIOTROWSKA B; ROZNIECKI J; UDEN S; WALTERS EH; WILLARD CJ
      EFFECT OF A NOVEL POTENT PLATELET-ACTIVATING-FACTOR ANTAGONIST, MODIPAFANT, IN CLINICAL ASTHMA

      American journal of respiratory and critical care medicine
    87. NISHI O; TOMINAGA T; GOTO Y; HAYASHI K; MORI T
      EFFECTS OF PLATELET-ACTIVATING-FACTOR ON MOUSE EMBRYO IMPLANTATION IN-VITRO

      Journal of assisted reproduction and genetics
    88. ONEILL C
      PLATELET-ACTIVATING FACTOR-ANTAGONISTS REDUCE IMPLANTATION IN MICE ATLOW-DOSES ONLY

      Reproduction, fertility and development
    89. FOSTER AP; LEES P; CUNNINGHAM FM
      ACTIONS OF PAF RECEPTOR ANTAGONISTS IN HORSES WITH THE ALLERGIC SKIN-DISEASE SWEET ITCH

      Inflammation research
    90. MEIJER F; VANDELFT JL; VANHAERINGEN NJ
      PLATELET-ACTIVATING-FACTOR - AN INFLAMMATORY MEDIATOR IN THE ACUTE-PHASE OF ALLERGIC CONJUNCTIVITIS IN A GUINEA-PIG MODEL

      Mediators of inflammation
    91. HUSSOIN MS; CAI X; SCANNELL RT; YAEGER D; KILLIAN DB; ECKMAN J; HWANG SB; LIBERTINEGARAHAN L; QIAN CG; YEH CG; IP S
      CMI-206 - A POTENT DUAL PLATELET-ACTIVATING-FACTOR ANTAGONIST AND 5-LIPOXYGENASE INHIBITOR

      Bioorganic & medicinal chemistry letters
    92. OKANO S; TAGAWA M; URAKAWA N
      EFFECT OF TCV-309, A NOVEL PLATELET-ACTIVATING-FACTOR ANTAGONIST, ON HEMODYNAMICS IN DOGS WITH ENDOTOXIN-INDUCED SHOCK

      Journal of veterinary medical science
    93. REDDY DS; SINGH M
      ANTIPEROXIDATIVE EFFECTS OF PLATELET-ACTIVATING-FACTOR ANTAGONISTS AGAINST IRON-DEPENDENT LIPID-PEROXIDATION IN MURINE VENTRICULAR MEMBRANES

      Methods and findings in experimental and clinical pharmacology
    94. HILLIQUIN P; GUINOT P; CHERMATIZARD V; PUECHAL X; MENKES CJ
      TREATMENT OF RHEUMATOID-ARTHRITIS WITH PLATELET-ACTIVATING-FACTOR ANTAGONIST BN-50730

      Journal of rheumatology
    95. DABROWSKI A; GABRYELEWICZ A; CHYCZEWSKI L
      THE EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONIST (BN-52021) ON ACUTE EXPERIMENTAL PANCREATITIS WITH REFERENCE TO MULTIORGAN OXIDATIVE STRESS

      International journal of pancreatology
    96. TAKADA Y; BOUDJEMA K; JAECK D; BELHAOUARI M; DOGHMI M; CHENARD MP; WOLF P; CINQUALBRE J
      EFFECTS OF PLATELET-ACTIVATING-FACTOR ANTAGONIST ON PRESERVATION REPERFUSION INJURY OF THE GRAFT IN PORCINE ORTHOTOPIC LIVER-TRANSPLANTATION

      Transplantation
    97. YANG HO; KANG YH; SUH DY; KIM YC; HAN BH
      BIOLOGICAL AND PHARMACOLOGICAL EFFECTS OF PINUSOLIDE, A NOVEL PLATELET-ACTIVATING-FACTOR ANTAGONIST

      Planta medica
    98. CASTROFARIANETO HC; ARAUJO CV; MOREIRA S; BOZZA PT; THOMAS G; BARBOSA JM; CORDEIRO RSB; TIBIRICA EV
      YANGAMBIN - A NEW NATURALLY-OCCURRING PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST - IN-VIVO PHARMACOLOGICAL STUDIES

      Planta medica
    99. TENG CM; LIN CH; KUO HP; KO FN; ISHII H; ISHIKAWA T; CHEN IS
      EFFECTS OF CIS-19, A NOVEL PAF RECEPTOR ANTAGONIST, ON PAF-INDUCED EOSINOPHIL RECRUITMENT AND ENHANCEMENT OF SUPEROXIDE ANION GENERATION INGUINEA-PIGS

      Naunyn-Schmiedeberg's archives of pharmacology
    100. MINOR T; ISSELHARD W; YAMAGUCHI T
      INVOLVEMENT OF PLATELET-ACTIVATING-FACTOR IN MICROCIRCULATORY DISTURBANCES AFTER GLOBAL HEPATIC ISCHEMIA

      The Journal of surgical research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 01:05:25